We are live on ! Find out more
ACH

Accendra Health

182 hedge funds and large institutions have $504M invested in Accendra Health in 2020 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 61 increasing their positions, 49 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

466% more call options, than puts

Call options by funds: $7.61M | Put options by funds: $1.34M

71% more capital invested

Capital invested by funds: $295M → $504M (+$209M)

24% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 49

17% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 30

1% more funds holding

Funds holding: 180 → 182 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3.19% less ownership

Funds ownership: 90.61% → 87.42% (-3.2%)

Holders
182
Holders Change
+2
Holders Change %
+1.11%
% of All Funds
4%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
35
Increased
61
Reduced
49
Closed
30
Calls
$7.61M
Puts
$1.34M
Net Calls
+$6.26M
Net Calls Change
+$4.72M

ACH Hedge Fund Activity: Q1 2020 in Review

182 of the 4,548 institutional investors tracked by Wall St. Rank reported a position in Accendra Health (ACH) for Q1 2020, worth a combined $504M — up 71% from $295M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new ACH positions and 30 closed out — a net gain of 5 holders — while 61 added to existing stakes and 49 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $8.11M. The largest seller was JP Morgan Chase, cutting an estimated $14.7M.

  • 182 institutional investors held Accendra Health (ACH) as of Q1 2020, up from 180 in Q4 2019.
  • Funds reported $504M of Accendra Health stock for Q1 2020, up 71% quarter-over-quarter.
  • 35 funds opened new Accendra Health positions in Q1 2020 and 30 closed out, a net change of +5 holders.
  • The largest Accendra Health buyer in Q1 2020 was Goldman Sachs, an estimated $8.11M added.
  • The largest Accendra Health seller in Q1 2020 was JP Morgan Chase, an estimated $14.7M sold.

Based on aggregated 13F filings for Q1 2020.